Philippines - English - FDA (Food And Drug Administration)

sanofi-aventis phils inc - insulin human (rdna) - solution for injection sc/iv - 100 iu/ml

Philippines - English - FDA (Food And Drug Administration)

sanofi-aventis phils inc - isophane insulin human (rdna origin) - suspension for injection sc - 100 iu/ml

Philippines - English - FDA (Food And Drug Administration)

sanofi-aventis phils inc - isophane insulin human (rdna origin) - suspension for injection sc - 100 iu/ml

Philippines - English - FDA (Food And Drug Administration)

sanofi-aventis phils inc - metoclopramide (as hydrochloride) - tablet - 10mg

Philippines - English - FDA (Food And Drug Administration)

sanofi-aventis phils inc - secnidazole - tablet - 500mg

Philippines - English - FDA (Food And Drug Administration)

sanofi aventis phils inc. - insulin glargine - solution for injection - 100 units/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - ciclopirox 8% - nail lacquer - 8 % - active: ciclopirox 8% excipient: butyl ester of pvm/ma copolymer ethyl acetate isopropyl alcohol nitrogen

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical cream - 1% w/w - active: ciclopirox olamine 1%{relative}

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical solution - 1% w/v - active: ciclopirox olamine 1%{relative}

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - neisseria meningitidis group a polysaccharide 50ug; neisseria meningitidis group c polysaccharide 50ug; neisseria meningitidis group w135 polysaccharide 50ug; neisseria meningitidis group y polysaccharide 50ug - injection with diluent - 0.5 ml - active: neisseria meningitidis group a polysaccharide 50ug neisseria meningitidis group c polysaccharide 50ug neisseria meningitidis group w135 polysaccharide 50ug neisseria meningitidis group y polysaccharide 50ug excipient: lactose monohydrate sodium chloride purified water - menomune® acyw-135 is indicated for active immunisation of adults and children older than 2 years against disease caused by neisseria meningitidis groups a, c, y and w-135, the major manifestation being meningococcal meningitis. vaccination may be considered for the following individuals: · travellers to countries recognised as having highly endemic or epidemic disease. · control of epidemics of infection caused by neisseria meningitidis groups a, c, y and w-135 in confined communities. · individuals at particular high risk of acquiring meningococcal infection, including persons with anatomic or functional asplenia. · close contacts of persons with meningococcal disease due to groups a, c, y and w-135, as an adjunct to appropriate chemoprophylaxis.